These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7573015)
21. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S BMC Nephrol; 2022 Feb; 23(1):59. PubMed ID: 35135481 [TBL] [Abstract][Full Text] [Related]
22. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. Ngugi NN; McLigeyo SO; Kayima JK East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416 [TBL] [Abstract][Full Text] [Related]
23. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. Di Iorio B; Torraca S; Piscopo C; Sirico ML; Di Micco L; Pota A; Tartaglia D; Berardino L; Morrone LF; Russo D J Nephrol; 2012; 25(5):653-60. PubMed ID: 21983985 [TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019 [TBL] [Abstract][Full Text] [Related]
25. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Gutzwiller JP; Schneditz D; Huber AR; Schindler C; Garbani E; Zehnder CE Clin Nephrol; 2003 Feb; 59(2):130-6. PubMed ID: 12608556 [TBL] [Abstract][Full Text] [Related]
26. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels]. Tuccillo S; Bellizzi V; Catapano F; Di Iorio B; Esposito L; Giannattasio P; Maione E; Mangiacapra S; Minutolo R; Zamboli P; Conte G; De Nicola L G Ital Nefrol; 2002; 19(4):439-45. PubMed ID: 12369047 [TBL] [Abstract][Full Text] [Related]
27. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. Kim HJ J Korean Med Sci; 1997 Apr; 12(2):111-6. PubMed ID: 9170015 [TBL] [Abstract][Full Text] [Related]
28. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease. Allon M; Dansby L; Shanklin N Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392 [TBL] [Abstract][Full Text] [Related]
29. Standardising dialysate potassium does not increase patient risk. Abeleda KL; Bennett PN; Ockerby C J Ren Care; 2013 Sep; 39(3):151-6. PubMed ID: 23902229 [TBL] [Abstract][Full Text] [Related]
30. Dialysate and serum potassium in hemodialysis. Hung AM; Hakim RM Am J Kidney Dis; 2015 Jul; 66(1):125-32. PubMed ID: 25828570 [TBL] [Abstract][Full Text] [Related]
31. Management of hyperkalemia in dialysis patients. Putcha N; Allon M Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250 [TBL] [Abstract][Full Text] [Related]
32. Mathematical Model of Potassium Profiling in Chronic Dialysis. Ursino M; Donati G Contrib Nephrol; 2017; 190():134-145. PubMed ID: 28535530 [TBL] [Abstract][Full Text] [Related]
33. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Musso CG Int Urol Nephrol; 2004; 36(3):469-72. PubMed ID: 15783126 [TBL] [Abstract][Full Text] [Related]
34. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study. Muñoz RI; Montenegro J; Salcedo A; Gallardo I; Martínez I; Quintanilla N; Saracho R; Lekuona I Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851 [TBL] [Abstract][Full Text] [Related]
35. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Manlucu J; Gallo K; Heidenheim PA; Lindsay RM Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632 [TBL] [Abstract][Full Text] [Related]
36. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Blumberg A; Weidmann P; Shaw S; Gnädinger M Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050 [TBL] [Abstract][Full Text] [Related]
37. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465 [TBL] [Abstract][Full Text] [Related]
38. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients. Siddiqi N; El Shahat O; Bokhari E; Roujouleh H; Hamid MH; Sheikh I; El-Sayed H; Saleh A; Seddik A Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864 [TBL] [Abstract][Full Text] [Related]
39. [The regulation of plasma aldosterone in hemodialysis patients]. Louis F; Zwahlen A; Favre H; Vallotton M Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078 [TBL] [Abstract][Full Text] [Related]
40. Low dialysate potassium and central arterial pressure waveform. Soveri I; Kals J Ups J Med Sci; 2015; 120(3):207-12. PubMed ID: 25951045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]